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ABSTRACT 
Objective: Establishing structural imaging correlates of psychosis symptoms in 
Alzheimer’s disease (AD) could localise pathology and target symptomatic treatment; 
this study investigated whether psychosis symptoms are associated with 
visuoperceptual or frontal networks, and whether any observed brain volume 
differences can be attributed to the paranoid (persecutory delusions) or misidentification 
(misidentification phenomena and/or hallucinations) subtypes. 
Methods: 104 patients with probable AD (AddNeuroMed; 47 psychotic, 57 non -- 
psychotic) were followed up for at least one year, with structural MRI data acquired at 
baseline. Presence and subtype of psychosis symptoms were established using the 
Neuropsychiatric Inventory. Volume and cortical thickness measures in visoperceptual 
and frontal networks were explored using multivariate analyses to compare by both a 
global (psychotic versus not) and subtype --specific approach, adjusting for potential 
confounding factors. 
Results: There was a significant main effect of psychosis subtypes on the ventral visual 
stream region of interest (F30,264=1.65, p=0.021, np2=0.16). This was explained by 
reduced left parahippocampal gyrus volume (F1,97 = 11.1, p = 0.001, np2 = 0.10). When 
comparisons were made across psychosis subtypes, left parahippocampal volume 
reduction remained significant (F7,95=3.94, p=0.011, np2=0.11), and was greatest in the 
misidentification and mixed subtypes.  
Conclusions: These findings implicate the ventral visual stream in psychosis in AD, 
consistent with integrative theories regarding origins of psychosis, and provide further 
evidence for a role in the misidentification subtype. Specifically, reduced volume in the 
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parahippocampal gyrus is implicated in misidentification delusion formation, which we 
hypothesise is due to its role in context attribution. 
 
INTRODUCTION 
Psychosis symptoms (delusions and hallucinations) occur in 41% of people with 
Alzheimer’s disease (AD), manifest early in the disease and are associated with 
accelerated decline. The functional anatomy of delusions in AD remains poorly 
understood, and there is a clinical imperative to further elucidate the pathophysiology of 
the psychosis endophenotype.1 Previously we have shown increased striatal D2/3 
receptor availability and poorer performance on the Rapid Visual Processing (RVP) test 
of sustained attention in AD patients with psychotic symptoms, consistent with data from 
young adults with schizophrenia, and supportive of corticostriatal dopaminergic network 
involvement.2,3 In a subsequent prospective study, we found reduced accuracy of 
performance on RVP and Incomplete Letters test from the Visual Object and Space 
Perception (VOSP) Battery in those with psychotic symptoms in AD, implicating the 
ventral visual pathway in addition to attentional networks.4 When psychotic patients 
were separated on the basis of paranoid (delusions of persecution and abandonment) 
and misidentification (misidentification phenomena and/or hallucinations) subtypes, 
poorer performance was largely explained by the misidentification subtype. Establishing 
whether this cognitive profile is underpinned by early volume loss, indicative of 
neuropathological change, forms the basis of the current investigation.  
This study aimed to test the hypothesis that AD patients with misidentification symptoms 
would have lower volume and/or thickness in brain regions which are functionally 
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connected to the ventral visual pathway, compared to paranoid and non -- psychotic 
groups. As several studies have reported more ‘frontal’ dysfunction in AD patients with 
psychotic symptoms,1 we also conducted an exploratory analysis in frontal regions. 
 
METHODS 
Sample 
Participants with possible or probable AD, with baseline MRI and carer -- rated 
Neuropsychiatric Inventory (NPI)5 data, were identified from the AddNeuroMed cohort.6 
Verbal and written informed consent was obtained from participant, or carer in those 
who lacked capacity. Study protocols were approved by relevant ethical committees. 
Demographic and clinical data was collected at baseline, and three, six, nine and 12 
month follow up. Patients were classified as ‘psychotic’ if delusions or hallucinations 
were rated ‘present’ on NPI at baseline or any follow up visit over the one year follow up 
period, with no threshold cut off for frequency x severity, as described previously.2-4 For 
the subtype analysis, ‘paranoid’ and ‘misidentification’ subtypes were defined as 
described in Table 1, based on the classification used by Cook et al.7 Patients who 
experienced both types of symptoms, were categorised as ‘mixed’. 
MRI Regions of Interest 
AddNeuroMed MRI data was acquired as previously described.8 All cortical volumes 
were normalized by total intracranial volume. Regions of interest (ROI) for 
visuoperceptual and frontal cortical networks (detailed in Table 3) were chosen from 
available measures of cortical volume and thickness.  
Statistical analyses 
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Statistical analyses were carried out using SPSS 19 (www.spss.com). Between -- group 
differences in demographic data were analysed using analysis of variance (ANOVA), 
Kruskal Wallis and chi -- squared tests.  Hypothesis testing was carried out using 
multiple analysis of covariance (MANCOVA). Each model included multiple dependent 
variables for either ventral visual or frontal cortical regions. Psychosis subtypes (non -- 
psychotic, paranoid, misidentification, mixed) and baseline medication (cognitive 
enhancers) were included as fixed factors and age, duration of illness and ADAS – cog 
(all measured at baseline) as covariates. Where a MANCOVA resulted in a significant 
main effect (p<0.05), data were submitted to separate ANCOVAs. As the analysis was 
hypothesis driven, no correction was made for multiple pairwise comparisons.  
 
RESULTS 
Demographic and clinical characteristics 
104 patients were studied (age 74.9 +- 5.9 years; 34 men (32.7%); MMSE 20.8 +- 4.7); 
47 (45.2%) of the sample had psychotic symptoms recorded at any one of the follow up 
visits; and 30 (28.8%) participants at baseline. Demographic and clinical data are shown 
in Table 2. Age and ADAS -- cog score differed significantly between groups. Patients 
in the non -- psychotic and misidentification groups were younger and had better ADAS 
-- cog performance than those with paranoid or mixed -- type symptoms.  
Hypothesis -- driven analysis 
Initial analysis by MANCOVA compared psychotic to non -- psychotic groups. There 
was a significant effect in the ventral visual stream for volume (F10,88 = 2.1, p = 0.036, 
np2 = 0.19). ANCOVAs of individual ROIs showed significant effect for volume of left 
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parahippocampal gyrus (mean regional cortical volume, normalised for total intracranial 
volume +-SD; 12.7 x 10-4 +-2.5 x 10-4 in non -- psychotic, compared to 10.6 x 10-4 +-2.3 
x 10-4 in psychotic participants; F1,97 = 11.1, p = 0.001, np2 = 0.10), and left lingual gyrus 
(35.2 x 10-4 +-7.0 x 10-4 in non -- psychotic, compared to 31.9 x 10-4 +-7.0 x 10-4 in 
psychotic participants; F1,97 = 5.6, p = 0.020, np2 = 0.05). There was no significant effect 
for cortical thickness in ventral visual stream (F10,89 = 1.5, p = 0.143, np2 = 0.15) or 
volume or thickness in frontal cortical ROI (F8,89 = 1.3, p = 0.244, np2 = 0.11; F8,91 = 0.4, 
p = 0.910, np2 = 0.04 respectively).  
As a significant effect had been found for the ventral visual stream ROI for volumes, 
further comparison was done by subtype, see Table 3. There was a significant main 
effect of psychosis subtype on ventral visual stream (F30,264=1.65, p=0.021, np2=0.16). 
ANCOVAs of individual ROIs showed a significant effect in relation to left and right 
parahippocampal gyri (F3,95 = 3.9, p =0.011, ηp2  = 0.11; F3,95 = 3.8, p =0.012, ηp2  = 
0.11), but were not significant for other regions. Post -- hoc pairwise comparisons 
showed significantly lower left parahippocampal volume in misidentification (p = 0.011) 
and mixed (p = 0.008) groups, but not in the paranoid group (p=0.093), compared to the 
non -- psychotic group, and significantly lower right parahippocampal volume only in the 
mixed group (p=0.002).  
 
DISCUSSION 
This study supports our primary hypothesis that volume loss would be seen in the 
ventral visual pathway in patients with psychosis and would be greatest in those with 
misidentification phenomena. The ventral visual stream is commonly thought of as the 
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‘what’ pathway of visual processing and includes the fusiform face area, the extrastriate 
body area, and the parahippocampal gyrus.9 The parahippocampal gyrus is considered 
to have a role in context memory, processing both the spatial and temporal context of 
visual information (remembering when or where something was seen before).10 It is the 
parahippocampal gyrus which is implicated by our findings, as differences in ventral 
stream volume between psychotic and non -- psychotic patients were largely accounted 
for by reduced volume in left parahippocampal gyrus, most markedly so in those with 
misidentification symptoms. In contrast to earlier studies,11,12 we did not find any 
significant difference in frontal cortical networks between psychotic and non-psychotic 
groups. As it appears that frontal atrophy may associate with misidentification 
delusions,11,13 it is possible that any such changes were not detected in this initial 
comparison due to the small number of individuals with misidentification-type symptoms 
in the psychotic group, or due to the relatively early stage of disease. The finding of left-
sided changes is also in contrast to previous literature, but is similar to previous study of 
delusions in the AddNeuroMed cohort.14 Reduced volume of left parahippocampal gyrus 
has been previously demonstrated in patients with schizophrenia,15 and in temporal lobe 
epilepsy with psychosis.16 As noted in previous studies imaging studies in AD, it is 
possible that measures of volume (being measured in more than one dimension) are 
more sensitive to earlier stages of atrophy, particularly in more complex structures.17 
The study was limited by small sample size in the subtype analysis, and the number of 
statistical comparisons which increased the possibility of type 1 error; as described, the 
p values quoted have not been corrected for multiple comparisons. However, our 
primary analysis was hypothesis driven and we restricted subtype analysis to networks 
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which showed significant differences between psychotic and non -- psychotic groups. 
As previously noted, both age and ADAS – cog showed significant differences between 
groups. While we have included these as covariates in modelling, they remain 
potentially confounding factors.  
Due to the small numbers in this study, we have not further divided the 
‘misidentification’ and ‘mixed’ group to explore how hallucinations affected results or the 
impact of gender. This is an area that could be considered in further study in a larger 
group. We also cannot completely rule out the possibility that a proportion of patients in 
misidentification or mixed groups may have undiagnosed Lewy Body dementia, given 
the occurrence of hallucinations at such an early stage. Greater pathology has certainly 
been demonstrated in the parahippocampus in those with visual hallucinations in Lewy 
Body dementia.18 In the current study we were also limited to the brain regions available 
in the pre-existing data set. A prospective study would allow the ventral visual steam to 
be explored in more detail, and in addition to using segregated topographical regions, 
could provide an opportunity to explore the findings of this study from a hodological 
perspective. 
Contemporary theories suggest that delusion formation requires the presence of a 
‘neuropsychological’ impairment that prompts the delusional belief and further disruption 
in belief evaluation mechanisms that would otherwise cause the delusional belief to be 
rejected.19 We would suggest that loss of volume in parahippocampal gyri, reflecting an 
impaired ability to correctly attribute context to visual information, may contribute to 
formation of misidentification delusions in AD. This will be investigated prospectively in 
future studies.   
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Table 1: Description and Classification of Psychotic Symptoms (n=  47): Neuropsychiatric Inventory (NPI)   
Domain Content Number (%) of psychotic patients 
who have experienced symptoms 
over the course of one year 
Delusions 1 In danger/others are planning to hurt him/her  P 23 (48.9) 
 2 Others are stealing from him/her  P 25 (53.2) 
 3 Spouse is having an affair  P 9 (19.1) 
 7 Family members plan to abandon him/her  P 5 (10.6) 
   
 4 Unwelcome guests are staying in his/her house  M 14 (29.8) 
 5 His/her spouse or others are not who they claim to be  M 10 (21.3) 
 6 His/her house is not his/her own  M 8 (17.0) 
 8 Television/magazine figures are present in his/her home  M 3 (6.4) 
   
Hallucinations  He/she can hear voices  M 15 (31.9) 
 Talks to people who are not there  M 13 (27.7) 
 Seeing things not seen by others   M 16 (34.0) 
 Smells odours not smelled by others 3 (6.4) 
 Feel things on his/her skin 4 (8.5) 
 Tastes without known cause 3 (6.4) 
 Any other unusual sensory experiences 10 (21.3) 
 
Content taken from items listed in the delusions and hallucinations domains of the NPI 
P items included in the paranoid subtype             M Items included in the misidentification subtype 
 
 
*Higher score = poorer performance 
Table 2: Demographic and Clinical Characteristics of Psychosis Subtypes at baseline 
 Non-Psychotic 
(n = 57) 
Paranoid 
 (n = 15) 
Misidentification 
(n= 10) 
Mixed 
(n = 22) 
Test df, p value   
Mean (SD) age (years) 73.4 (5.8) 77.5 (4.8) 74.8 (6.1) 76.9 (5.7) ANOVA, F3,100 =3.2, p=0.03 
Number (%) men 21 (36.8) 4 (26.7) 2 (20) 7 (31.8) x,  3 df, p=0.70 
Mean (SD) duration of 
illness  (years) 
3.4 (2.5) 2.6 (1.8) 2.8 (2.6) 4.0 (2.9) Kruskal Wallis, 3 df, p=0.43 
Mean (SD) MMSE 21.3 (4.8) 19.9 (4.2) 21.9 (4.0) 19.7 (5.1) Kruskal Wallis, 3 df, p=0.39 
Mean (SD) ADAS-cog* 21.9 (9.0) 26.9 (9.5) 23.8 (12.0) 28.9 (10.5) ANOVA, F3,100=3.2 p=0.03 
Number (%) prescribed 
cholinesterase inhibitor 
and/or memantine 
44 (77.2) 10 (66.7) 9 (90.0) 21 (95.5) x, 3 df, p=0.11 
Number (%) prescribed 
antipsychotic medication 
2 (3.5) 0 (0) 1 (10) 2 (9.1) x , 3 df, p=0.43 
Neuropsychiatric 
Inventory: Mean total 
score for delusions and 
hallucinations (SD) 
- 2.5 (2.1) 
 
2.6 (2.3) 3.4 (2.4) Kruskal Wallis, 2 df, p=0.38 
ADL (total score) 54.0 (14.0) 52.9 (7.6) 46.8 (20.4) 44.5 (19.1) Kruskal Wallis, 3 df, p=0.13 
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All volumes (SD) x 10-4 
 
F ratio, p value and ηp2 values are presented for each MANCOVA, adjusting for age, illness duration, and 
baseline ADAS-COG. Medication status was included as a fixed factor.   
 
MANCOVA for ventral visual stream thickness was not significant (F10,89 = 1.5, p = 0.143, np2 = 0.15), nor 
were MANCOVA for frontal cortical ROI (rostral and caudal anterior cingulate cortex, rostral middle frontal 
gyrus and medial orbitofrontal cortex) for volume or thickness (F8,89 = 1.3, p = 0.244, np2 = 0.11; F8,91 = 
0.4, p = 0.910, np2 = 0.04 respectively) 
 
Table 3. Multivariate analysis of regional cortical volume (normalised for total intracranial volume) across psychosis 
subtypes 
Regions Non-
psychotic  
(n = 56) 
Paranoid 
(n = 15) 
Misidentification  
(n = 10) 
Mixed   
(n = 22) 
Subtype analysis 
Fdf, p, ηp2 
Visuoperceptual  
(ventral visual stream) 
    
F30,264=1.65, p=0.021, np2=0.16 
Left entorhinal cortex 9.2 (3.5) 8.8 (3.1) 9.4 (3.7) 7.5 (2.5) F7,95=0.48, p=0.700, np2=0.02 
Right entorhinal cortex 9.4 (2.5) 9.3 (2.5) 10.0 (6.0) 7.8 (2.0) F7,95=1.09, p=0.358, np2=0.03 
Left parahippocampal gyrus 12.7 (2.5) 11.2 (2.3) 10.3 (3.1) 10.4 (1.8) F7,95=3.94, p=0.011, np2=0.11 
Right parahippocampal gyrus 11.6 (2.7) 11.1 (1.8) 12.0 (3.4) 9.3 (1.3) F7,95=3.82, p=0.012, np2=0.11 
Left lateral occipital cortex 61.2 (11.1) 57.7 (7.1) 54.8 (12.2) 
60.0 
(12.3) 
F7,95=1.17, p=0.324, np2=0.04 
Right lateral occipital cortex 60.3 (8.6) 59.9 (7.7) 55.8 (10.1) 
58.0 
(10.4) 
F7,95=0.82, p=0.488, np2=0.03 
Left fusiform gyrus 49.7 (9.0) 48.9 (7.0) 45.3 (5.1) 47.2 (9.2) F7,95=0.98, p=0.406, np2=0.03 
Right fusiform gyrus 47.4 (8.0) 47.2 (7.6) 45.7 (6.7) 42.8 (6.5) F7,95=2.50, p=0.064, np2=0.07 
Left lingual gyrus 35.2 (7.0) 31.2 (5.3) 31.6 (10.9) 32.6 (6.0) F7,95=1.92, p=0.131, np2=0.06 
Right lingual gyrus 34.6 (5.4) 31.6 (6.0) 30.3 (9.1) 32.0 (4.8) F7,95=1.58, p=0.199, np2=0.05 
